Markoff, John. What the Dormouse Said: How the Sixties Counterculture Shaped the Personal
Computer Industry. New York: Penguin, 2005.
Moore, Gerald, and Larry Schiller. “The Exploding Threat of the Mind Drug That Got out of
Control.” Life, March 25, 1966.
Moreno, Francisco A., Christopher B. Wiegand, E. Keolani Taitano, and Pedro L. Delgado. “Safety,
Tolerability, and Efficacy of Psilocybin in 9 Patients with Obsessive-Compulsive Disorder.”
Journal of Clinical Psychiatry 67, no. 11 (2006): 1735–40. doi:10.4088/JCP.v67n1110.
Nagel, Thomas. “What Is It Like to Be a Bat?” Philosophical Review 83, no. 4 (1974): 435–50.
doi:10.2307/2183914.
Nichols, David E. “Commentary On: Psilocybin Can Occasion Mystical-Type Experiences Having
Substantial and Sustained Personal Meaning and Spiritual Significance.” Psychopharmacology
187, no. 3 (2006): 284–86. doi:10.1007/s00213-006-0457-5.
———. “LSD: Cultural Revolution and Medical Advances.” Chemistry World 3, no. 1 (2006): 30–
34.
———. “Psychedelics.” Pharmacological Reviews 68, no. 2 (2016): 264–355.
Nour, Matthew M., Lisa Evans, and Robin L. Carhar-Harris. “Psychedelics, Personality and
Political Perspectives.” Journal of Psychoactive Drugs (2017): 1–10.
Novak, Steven J. “LSD Before Leary: Sidney Cohen’s Critique of 1950s Psychedelic Drug
Research.” History of Science Society 88, no. 1 (1997): 87–110.
Nutt, David. “A Brave New World for Psychology?” Psychologist 27, no. 9 (2014): 658–60.
doi:10.1097/NMD.0000000000000113.
———. Drugs Without the Hot Air: Minimising the Harms of Legal and Illegal Drugs.
Cambridge, England: UIT Cambridge, 2012.
Osmond, Humphry. “On Being Mad.” Saskatchewan Psychiatric Services Journal 1, no. 2 (1952).
———. “A Review of the Clinical Effects of Psychotomimetic Agents.” Annals of the New York
Academy of Sciences 66, no. 1 (1957): 418–34.
Pahnke, Walter, “The Psychedelic Mystical Experience in the Human Encounter with Death.”
Harvard Theological Review 62, no. 1 (1969): 1–22.
“Pass It On”: The Story of Bill Wilson and How the A.A. Message Reached the World. New York:
Alcoholics Anonymous World Services, 1984.
Petri, G., P. Expert, F. Turkheimer, R. Carhart-Harris, D. Nutt, P. J. Hellyer, and F. Vaccarino.
“Homological Scaffolds of Brain Functional Networks.” Journal of the Royal Society Interface
11, no. 101 (2014).
Piff, Paul K., Pia Dietze, Matthew Feinberg, Daniel M. Stancato, and Dacher Keltner. “Awe, the
Small Self, and Prosocial Behavior.” Journal of Personality and Social Psychology 108, no. 6
(2015): 883–99. doi:10.1037/pspi0000018.
Pollan, Michael. “The Trip Treatment.” New Yorker, Feb. 9, 2015.
Preller, Katrin H., Marcus Herdener, Thomas Pokorny, Amanda Planzer, Rainer Krahenmann,
Philipp Stämpfli, Matthias E. Liechti, Erich Seifritz, and Franz X. Vollenweider. “The Fabric of
Meaning and Subjective Effects in LSD-induced States Depend on Serotonin 2A Receptor
Activation.” Current Biology 27, no. 3 (2017): 451–57.
Presti, David, and Jerome Beck. “Strychnine and Other Enduring Myths: Expert and User Folklore
Surrounding LSD.” In Psychoactive Sacramentals: Essays on Entheogens and Religion, edited
by Thomas B. Roberts, 125–35. San Francisco: Council on Spiritual Practices, 2001.
frankie
(Frankie)
#1